Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:GNVC

GenVec (GNVC) Stock Price, News & Analysis

GenVec logo

About GenVec Stock (NASDAQ:GNVC)

Advanced Chart

Key Stats

Today's Range
$7.19
$7.19
50-Day Range
N/A
52-Week Range
$2.70
$10.44
Volume
N/A
Average Volume
259,136 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive GNVC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GenVec and its competitors with MarketBeat's FREE daily newsletter.

GNVC Stock News Headlines

Cold virus can hunt down cancer
Huangshan Novel Co Ltd Class A 002014
A new rule goes live in July — and the banks are quietly cashing in
A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.
GenVec Stock Hit by Pancreas Study's Details
Early Volume Plays: Novavax, GenVec
GenVec Value Slammed on Drug Failure
See More Headlines

GNVC Stock Analysis - Frequently Asked Questions

GenVec Inc (NASDAQ:GNVC) issued its quarterly earnings results on Friday, November, 4th. The biopharmaceutical company reported ($0.05) EPS for the quarter, topping analysts' consensus estimates of ($0.08) by $0.03. The biopharmaceutical company earned $0.17 million during the quarter, compared to the consensus estimate of $0.07 million.

GenVec shares reverse split on the morning of Thursday, December 1st 2016.The 1-10 reverse split was announced on Wednesday, November 16th 2016. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, November 30th 2016. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that GenVec investors own include Meta Platforms (META), Sarepta Therapeutics (SRPT), Alibaba Group (BABA), NVE (NVEC), Microbot Medical (MBOT) and Pluristem Therapeutics (PSTI).

Company Calendar

Last Earnings
11/04/2016
Today
7/12/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
NASDAQ:GNVC
CIK
934473
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

This page (NASDAQ:GNVC) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners